LAS VEGAS, July 7, 2011 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced today that CorCell, its domestic brand for cord blood stem cell collection and storage, has a launched a new Referral Rewards Program in the U.S. for the collection of a baby's umbilical cord blood.
The new program offers $200 to anyone making a referral and a $200 discount on the enrollment fee for the family that has been referred. "We know how important it is to save a baby's stem cells at the time of birth and we hope friends tell friends to take advantage of our new program," said Kristin Eber, Director of Marketing.
"We see great potential in this program and we are confident it will add many new clients," said Matthew Schissler, CEO and co-founder. "The Referral Rewards program is open to everyone. Historically our business has had a great volume of referrals, but mostly from within our customer base. This plan opens it up to everyone and offers incentive for referring CorCell's world class stem cell storage services. We anticipate seeing both one-time referrals and individuals crafting a business around this income stream."
Details of the Referral Rewards program can be found here: http://www.corcell.com/customers/referral-rewards/newform.aspx
Cord blood stem cells are used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies, while research is ongoing to determine the usefulness of stem cells in combating some of the nation's most serious diseases, including diabetes, heart disease, Parkinson's and other diseases for which there is currently no cure.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
